Evidence map›Paper›PMID 34883678›Full record

ArticlePolymers2021

Nano Drug Delivery Platforms for Dental Application: Infection Control and TMJ Management-A Review.

Abhishek Lal, Mohammad Khursheed Alam, Naseer Ahmed, Afsheen Maqsood, Ruba K Al-Qaisi, Deepti Shrivastava, Zainab Ali Alkhalaf, Amal Mohamed Alanazi, Hasna Rasheed Alshubrmi, Mohammed G Sghaireen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 5 countries.

Abhishek LalDepartment of Prosthodontic, Altamash Institute of Dental Medicine, Karachi 75500, Pakistan.ORCID 0000-0002-0018-7069
Mohammad Khursheed AlamOrthodontics, Department of Preventive Dentistry, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia.
Naseer AhmedDepartment of Prosthodontic, Altamash Institute of Dental Medicine, Karachi 75500, Pakistan.ORCID 0000-0002-0960-1123
Afsheen MaqsoodDepartment of Oral Pathology, Bahria University Dental College, Karachi 75530, Pakistan.
Ruba K Al-QaisiProsthodontic Dentistry Department, Jordanian Royal Medical Services, Amman 11180, Jordan.ORCID 0000-0001-6475-6796
Deepti ShrivastavaPeriodontics, Department of Preventive Dentistry, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia.ORCID 0000-0002-1073-9920
Zainab Ali AlkhalafProsthodontic Dentistry Department, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia.
Amal Mohamed AlanaziProsthodontic Dentistry Department, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia.
Hasna Rasheed AlshubrmiProsthodontic Dentistry Department, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia.
Mohammed G SghaireenProsthodontic Dentistry Department, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia.
Kumar Chandan SrivastavaOral Medicine & Radiology, Department of Oral & Maxillofacial Surgery & Diagnostic Sciences, College of Dentistry, Jouf University, Sakaka 72345, Saudi Arabia.ORCID 0000-0002-5969-6810
Jouf University · SAKarachi Medical and Dental College · PKBahria University · PKKing Hussein Medical Center · JO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oral cavity is an intricate environment subjected to various chemical, physical, and thermal injuries. The effectiveness of the local and systemically administered drugs is limited mainly due to their toxicities and poor oral bioavailability that leads to the limited effectiveness of the drugs in the target tissues. To address these issues, nanoparticle drug delivery systems based on metals, liposomes, polymeric particles, and core shells have been developed in recent years. Nano drug delivery systems have applications in the treatment of patients suffering from temporomandibular joint disorders such as preventing degeneration of cartilage in patients suffering from rheumatoid arthritis and osteoarthritis and alleviating the pain along with it. The antibacterial dental applications of nano-drug delivery systems such as silver and copper-based nanoparticles include these agents used to arrest dental caries, multiple steps in root canal treatment, and patients suffering from periodontitis. Nanoparticles have been used in adjunct with antifungals to treat oral fungal infections such as candida albicans in denture wearers. Acyclovir being the most commonly used antiviral has been used in combination with nanoparticles against an array of viral infections such as the herpes simplex virus. Nanoparticles based combination agents offer more favorable drug release in a controlled manner along with efficient delivery at the site of action. This review presents an updated overview of the recently developed nanoparticles delivery systems for the management of temporomandibular joint disorders along with the treatment of different oral infections.

Indexed as

COVID-19drug delivery systemsnanomedicinenanoparticlesoral infectionstemporomandibular joint

Identifiers

PMID34883678
PMCPMC8659450
OpenAlexW3215855844

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.